Kypha
Kypha Inc. is a life sciences company focused on developing and commercializing in-vitro diagnostic biomarker tests for inflammation and autoimmune disorders. Based in St. Louis, Missouri, the company offers the COMP ACT System, which enhances the monitoring and treatment of various health conditions, including lupus, stroke, traumatic brain injury, preeclampsia, infection, kidney disease, and transplant rejection. Kypha aims to provide rapid and accurate assessments of inflammation levels, enabling healthcare professionals to make timely and informed clinical decisions. With a core team supported by scientific advisors and clinical collaborators, Kypha has successfully secured federal grants and raised private capital to advance its diagnostic products toward regulatory approval and market launch. The company's technology is designed for scalability, facilitating testing in diverse settings from home health to clinical laboratories, ultimately improving patient outcomes through timely intervention.
Biosensia Ltd. is a company based in Dublin, Ireland, that specializes in point-of-care in-vitro diagnostics. It has developed RapiPlex, an innovative diagnostic platform designed to provide both quantitative and qualitative laboratory test results. RapiPlex consists of a disposable assay cartridge and a compact tabletop instrument, allowing for the transition of complex immunoassays from centralized laboratories to doctors' offices or patients' bedsides. This advancement supports near-patient care without sacrificing analytical performance. The platform is versatile, capable of analyzing various biological samples such as whole blood, plasma, serum, urine, saliva, and milk. Biosensia also focuses on applications in theranostics, veterinary testing, and food safety. The company was founded in 2000 and was previously known as NanoComms Ltd. Biosensia operates as a subsidiary of Kypha Inc. since 2018.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.